CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,269,913 | -18.7% | 1,024,139 | -40.3% | 0.03% | -24.4% |
| Q2 2023 | $18,777,257 | +10.0% | 1,714,818 | -12.4% | 0.04% | -4.7% |
| Q1 2023 | $17,065,633 | +4822.0% | 1,957,068 | +3439.1% | 0.04% | +4200.0% |
| Q4 2022 | $346,725 | -39.7% | 55,299 | -31.1% | 0.00% | -75.0% |
| Q2 2019 | $575,000 | -18.7% | 80,264 | +50.7% | 0.00% | -20.0% |
| Q1 2019 | $707,000 | -63.2% | 53,247 | -78.2% | 0.01% | -64.3% |
| Q4 2018 | $1,921,000 | +7904.2% | 244,066 | +1837.0% | 0.01% | – |
| Q3 2015 | $24,000 | -38.5% | 12,600 | -12.0% | 0.00% | – |
| Q2 2015 | $39,000 | – | 14,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |